News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
668,740 Results
Type
Article (52717)
Company Profile (362)
Press Release (615661)
Section
Business (192271)
Career Advice (2128)
Deals (32762)
Drug Delivery (114)
Drug Development (82007)
Employer Resources (162)
FDA (16085)
Job Trends (14297)
News (328216)
Policy (30325)
Tag
Academia (2839)
Alliances (49318)
Alzheimer's disease (1385)
Approvals (16021)
Artificial intelligence (183)
Bankruptcy (312)
Best Places to Work (11438)
Biotechnology (255)
Breast cancer (215)
Cancer (1653)
Cardiovascular disease (138)
Career advice (1784)
CAR-T (126)
Cell therapy (358)
Clinical research (65329)
Collaboration (625)
Compensation (302)
COVID-19 (2755)
C-suite (147)
Data (1519)
Diabetes (206)
Diagnostics (6200)
Earnings (73050)
Employer resources (145)
Events (104433)
Executive appointments (514)
FDA (16889)
Funding (550)
Gene therapy (249)
GLP-1 (721)
Government (4488)
Healthcare (18876)
Infectious disease (2860)
Inflammatory bowel disease (126)
Interviews (366)
IPO (15894)
Job creations (3320)
Job search strategy (1526)
Layoffs (475)
Legal (6330)
Lung cancer (251)
Manufacturing (240)
Medical device (13223)
Medtech (13227)
Mergers & acquisitions (17172)
Metabolic disorders (556)
Neuroscience (1793)
NextGen: Class of 2025 (6492)
Non-profit (4502)
Northern California (1893)
Obesity (318)
Opinion (233)
Patents (140)
People (56827)
Phase I (20559)
Phase II (28935)
Phase III (21508)
Pipeline (641)
Postmarket research (2356)
Preclinical (8785)
Radiopharmaceuticals (260)
Rare diseases (324)
Real estate (5764)
Regulatory (21195)
Research institute (2572)
Resumes & cover letters (316)
Southern California (1635)
Startups (3772)
United States (17017)
Vaccines (660)
Weight loss (241)
Date
Today (133)
Last 7 days (482)
Last 30 days (2150)
Last 365 days (35865)
2025 (2057)
2024 (36287)
2023 (40995)
2022 (52189)
2021 (56517)
2020 (54377)
2019 (46688)
2018 (35556)
2017 (33301)
2016 (32376)
2015 (37898)
2014 (29574)
2013 (24701)
2012 (26255)
2011 (26873)
2010 (23969)
Location
Africa (807)
Arizona (142)
Asia (40643)
Australia (6975)
California (4325)
Canada (1557)
China (385)
Colorado (186)
Connecticut (209)
Europe (91703)
Florida (618)
Georgia (154)
Illinois (423)
Indiana (223)
Maryland (726)
Massachusetts (3412)
Michigan (193)
Minnesota (323)
New Jersey (1204)
New York (1224)
North Carolina (867)
Northern California (1893)
Ohio (162)
Pennsylvania (983)
South America (1098)
Southern California (1635)
Texas (636)
Utah (128)
Washington State (442)
668,740 Results for "als therapy development institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Esri Technology Used By ALS Therapy Development Institute to Map Clinical Trials
The ALS Therapy Development Institute (ALS TDI), a nonprofit biotech dedicated to ending amyotrophic lateral sclerosis (ALS), has used mapping technology from Esri, the global leader in location intelligence, to develop the ALS Trial Navigator.
June 21, 2024
·
4 min read
Regulatory
FDA Presses Pause on Atara’s Programs, Play on Amylyx’s ALS Assets
The FDA is putting Atara’s active Investigational New Drug applications on hold due to manufacturing concerns at a third-party provider while releasing Amylyx’s investigational ALS therapy from a previous pause.
January 22, 2025
·
2 min read
·
Tristan Manalac
ALS
HEALEY ALS Trial Serves Up More Disappointment as Denali, AbbVie/Calico Fail
Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the latest setbacks for the controversial platform trial, the results from which have largely mirrored the dismal success rate in ALS overall.
January 10, 2025
·
5 min read
·
Heather McKenzie
Press Releases
The ALS Association Announces 2025 ‘ALS Nexus’ Conference
January 17, 2025
·
3 min read
Press Releases
QurAlis Doses First Patient With ALS in Phase 1 Clinical Trial Evaluating QRL-101, a First-in-Class Kv7 Precision Therapy for ALS
December 4, 2024
·
4 min read
Press Releases
MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND
December 6, 2024
·
6 min read
Press Releases
Mitsubishi Tanabe Pharma America to Present New ALS Research at MNDA’s 35th International Symposium on ALS/MND
December 3, 2024
·
9 min read
Press Releases
Aclipse Therapeutics Selected to Present M102 ALS Clinical Development Program at Prestigious ALS and Motor Neurone Disease Symposia
November 7, 2024
·
3 min read
Press Releases
NRG Therapeutics Awarded Grant Funding from Target ALS to Support the Development of mPTP Inhibitors as Novel Treatments for ALS/MND
September 5, 2024
·
4 min read
Press Releases
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND
December 9, 2024
·
5 min read
1 of 66,874
Next
